Stephen Elias Gellis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatitis Herpetiformis | 2 | 2017 | 24 | 0.600 |
Why?
|
| Dapsone | 1 | 2017 | 56 | 0.570 |
Why?
|
| Epidermolysis Bullosa Acquisita | 2 | 2015 | 15 | 0.550 |
Why?
|
| Pemphigus | 2 | 2017 | 116 | 0.540 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 223 | 0.500 |
Why?
|
| Purpura | 1 | 2012 | 116 | 0.400 |
Why?
|
| Skin | 6 | 2021 | 4466 | 0.390 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2012 | 169 | 0.370 |
Why?
|
| Neurofibromatosis 1 | 1 | 2016 | 560 | 0.370 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 981 | 0.340 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 693 | 0.330 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 2 | 2019 | 70 | 0.240 |
Why?
|
| Skin Neoplasms | 3 | 2021 | 5799 | 0.240 |
Why?
|
| Skin Diseases | 1 | 2012 | 1089 | 0.230 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 1231 | 0.230 |
Why?
|
| Antirheumatic Agents | 1 | 2012 | 1374 | 0.210 |
Why?
|
| Granuloma, Pyogenic | 1 | 2021 | 47 | 0.190 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2020 | 84 | 0.160 |
Why?
|
| Chickenpox Vaccine | 1 | 2018 | 40 | 0.150 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 12968 | 0.150 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2018 | 57 | 0.150 |
Why?
|
| Skin Diseases, Genetic | 1 | 2018 | 49 | 0.150 |
Why?
|
| Hyperkeratosis, Epidermolytic | 1 | 1996 | 7 | 0.140 |
Why?
|
| Herpesvirus 3, Human | 1 | 2018 | 158 | 0.140 |
Why?
|
| Erythema | 1 | 2018 | 262 | 0.140 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2000 | 537 | 0.130 |
Why?
|
| Herpes Zoster | 1 | 2018 | 251 | 0.130 |
Why?
|
| HELLP Syndrome | 1 | 1993 | 40 | 0.110 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 1993 | 61 | 0.100 |
Why?
|
| Ectodermal Dysplasia | 2 | 2004 | 106 | 0.100 |
Why?
|
| Immune System Diseases | 1 | 2015 | 258 | 0.100 |
Why?
|
| Hand, Foot and Mouth Disease | 1 | 2012 | 25 | 0.100 |
Why?
|
| Psoriasis | 1 | 2000 | 940 | 0.100 |
Why?
|
| Enterovirus | 1 | 2012 | 67 | 0.100 |
Why?
|
| Child, Preschool | 9 | 2019 | 42056 | 0.100 |
Why?
|
| Acrodermatitis | 1 | 1991 | 15 | 0.100 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1991 | 97 | 0.100 |
Why?
|
| Fibrosarcoma | 1 | 2012 | 308 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2016 | 1112 | 0.090 |
Why?
|
| Erythema Multiforme | 1 | 2009 | 31 | 0.080 |
Why?
|
| Nose Neoplasms | 1 | 2011 | 249 | 0.080 |
Why?
|
| Oral Ulcer | 1 | 2009 | 96 | 0.080 |
Why?
|
| Diarrhea | 1 | 2015 | 1319 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1832 | 0.080 |
Why?
|
| Hand | 1 | 2012 | 903 | 0.070 |
Why?
|
| Adolescent | 10 | 2021 | 87809 | 0.060 |
Why?
|
| Vaccination | 1 | 2018 | 3359 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 2421 | 0.060 |
Why?
|
| Lyme Disease | 1 | 1991 | 630 | 0.060 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 1986 | 85 | 0.060 |
Why?
|
| Arthralgia | 1 | 2009 | 461 | 0.060 |
Why?
|
| Neutropenia | 1 | 2009 | 884 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2012 | 1152 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11070 | 0.050 |
Why?
|
| Pediatrics | 1 | 1998 | 3586 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2011 | 892 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 1758 | 0.050 |
Why?
|
| Humans | 25 | 2021 | 760613 | 0.050 |
Why?
|
| Hypohidrosis | 1 | 2002 | 29 | 0.050 |
Why?
|
| Child | 9 | 2020 | 79799 | 0.050 |
Why?
|
| Melanoma | 2 | 2019 | 5697 | 0.050 |
Why?
|
| Fever | 1 | 2009 | 1617 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9185 | 0.050 |
Why?
|
| Carcinoma | 1 | 2012 | 2331 | 0.050 |
Why?
|
| Infant | 9 | 2018 | 36053 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2015 | 26179 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2004 | 857 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 1993 | 2942 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2004 | 2486 | 0.040 |
Why?
|
| Male | 11 | 2019 | 359718 | 0.040 |
Why?
|
| Female | 13 | 2019 | 391246 | 0.040 |
Why?
|
| Biopsy | 2 | 2021 | 6771 | 0.040 |
Why?
|
| Hyalin | 1 | 1996 | 34 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2009 | 2160 | 0.030 |
Why?
|
| Lymphomatoid Papulosis | 1 | 1995 | 16 | 0.030 |
Why?
|
| Vacuoles | 1 | 1996 | 229 | 0.030 |
Why?
|
| Keratins | 1 | 1996 | 497 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2019 | 733 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1996 | 573 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2018 | 559 | 0.030 |
Why?
|
| Epidermis | 1 | 1996 | 529 | 0.030 |
Why?
|
| Eosinophils | 1 | 2018 | 944 | 0.030 |
Why?
|
| Prognosis | 1 | 2012 | 29661 | 0.020 |
Why?
|
| Leg Dermatoses | 1 | 1991 | 20 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2145 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 1993 | 344 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1996 | 1516 | 0.020 |
Why?
|
| Hand Dermatoses | 1 | 1991 | 62 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 378 | 0.020 |
Why?
|
| Pigmentation Disorders | 1 | 1991 | 105 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2471 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1998 | 2773 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7268 | 0.020 |
Why?
|
| Mutation | 2 | 2004 | 29957 | 0.020 |
Why?
|
| Ankle | 1 | 1991 | 350 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3802 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 2693 | 0.020 |
Why?
|
| Atrophy | 1 | 1991 | 1626 | 0.020 |
Why?
|
| Epidermolysis Bullosa | 1 | 1986 | 29 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2011 | 1083 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1991 | 1468 | 0.020 |
Why?
|
| Pemphigoid, Bullous | 1 | 1986 | 114 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1991 | 9288 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10442 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4167 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 251 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10755 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3454 | 0.010 |
Why?
|
| Hepatitis | 2 | 1954 | 231 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9278 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39262 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2002 | 1870 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2002 | 1889 | 0.010 |
Why?
|
| Hepatitis A | 1 | 1954 | 132 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 4122 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 2203 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 58748 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64981 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2002 | 3442 | 0.010 |
Why?
|
| Pregnancy | 1 | 1993 | 29746 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 8311 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13451 | 0.010 |
Why?
|
| United States | 1 | 1998 | 72448 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80345 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17790 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 17624 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 1954 | 596 | 0.010 |
Why?
|
| Amino Acids | 1 | 1954 | 1714 | 0.000 |
Why?
|
| Albumins | 1 | 1948 | 577 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1948 | 674 | 0.000 |
Why?
|
| Plasma | 1 | 1948 | 584 | 0.000 |
Why?
|
| Hepatitis B | 1 | 1948 | 701 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1948 | 1435 | 0.000 |
Why?
|
| Time Factors | 1 | 2002 | 40139 | 0.000 |
Why?
|
| Adult | 1 | 1993 | 220007 | 0.000 |
Why?
|